Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Gains from Investment Securities (2020 - 2025)

Immuneering's Gains from Investment Securities history spans 6 years, with the latest figure at -$2093.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 61.73% to -$2093.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$8877.0, a 30.85% decrease, with the full-year FY2025 number at -$2093.0, up 69.15% from a year prior.
  • Gains from Investment Securities came in at -$2093.0 for Q4 2025, up from -$5469.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.8 million in Q2 2022, with the low at -$5469.0 in Q4 2024.
  • Historically, Gains from Investment Securities has averaged $796726.2 across 5 years, with a median of -$741.5 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: surged 833.83% in 2021 and later plummeted 122.68% in 2024.
  • Year by year, Gains from Investment Securities stood at $1.5 million in 2021, then plummeted by 100.36% to -$5170.0 in 2022, then soared by 52.5% to -$2456.0 in 2023, then plummeted by 122.68% to -$5469.0 in 2024, then soared by 61.73% to -$2093.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for IMRX at -$2093.0 in Q4 2025, -$5469.0 in Q4 2024, and -$1315.0 in Q3 2024.